Ymmunobio
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Gartengasse 12, Riehen, Basel-Stadt, 412...Website
www.ymmunobio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ymmunobio
Ymmunobio focuses on precision cancer treatments and immuno-oncology, emphasizing innovative biologics and first-in-class therapeutic targets. Founded in 2021 by Dr. Katrin Rupalla and Dr. Peter Schiemann, the company aims to advance preclinical research in solid tumors. With a distinguished team of scientific and clinical leaders, Ymmunobio is dedicated to transforming the treatment of cancer and autoimmune diseases. Their commitment is toward developing transformative therapeutics for various cancer indications.Explore more
Ymmunobio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ymmunobio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ymmunobio launches new products
Funding: Get notified immidiatlly once Ymmunobio has new funding data
Click to see if Ymmunobio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ymmunobio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ymmunobio
Check if Ymmunobio has recently received funding, and reach out quickly before it becomes old news!
Ymmunobio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ymmunobio is spiking on competitors!
Recommended Actions
Find VP level buyers at Ymmunobio
Find more new buyers
Company Profile Activity
Activity Insights
Ymmunobio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ymmunobio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ymmunobio.
Ymmunobio Tech Stack
A closer look at the technologies used by Ymmunobio
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Person-Based
Person-Based
Person-Based
Ymmunobio News & Media
Ymmunobio and PSI Secure Innosuisse Grant to Advance Radio-pharmaceutical YB-800
PRINCETON, N.J., Jan. 23, 2025 /PRNewswire/ -- Ymmunobio (YB) is excited to share that they in collaboration with the Paul Scherrer Institute (PSI) have received Innosuisse support to develop innovative radioactive loaded antibodies for the treatment and diagnostic of solid tumors based...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ymmunobio
Sign Up For FreeTo access detailed company insights
Ymmunobio focuses on precision cancer treatments and immuno-oncology, emphasizing innovative biologics and first-in-class therapeutic targets. Founded in 2021 by Dr. Katrin Rupalla and Dr. Peter Schiemann, the company aims to advance preclinical research in solid tumors. With a distinguished team of scientific and clinical leaders, Ymmunobio is ded... Read More
